Cover Image
Market Research Report

Asia Pacific Biochips Market Forecast 2019-2027

Published by Inkwood Research Product code 603655
Published Content info 88 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia Pacific Biochips Market Forecast 2019-2027
Published: March 9, 2019 Content info: 88 Pages
Description

KEY FINDINGS

The revenue generated by the Asia-Pacific biochip market is expected to increase from $XX million in 2018 and reach up to $XX million by 2027, progressing with an estimated CAGR of 21.30% between the forecast years of 2019-2027.

The microarray market is influential for the advancement of the biochip market. Therefore, the development of microarray technologies and improvements in research infrastructure facilities are key growth drivers of the microarray market in the Asia Pacific, which is further proliferating the regional market for biochip technologies.

MARKET INSIGHTS

Technological advancement in biotechnology, the rising number of applications for biochips and the overall scope for biotechnological growth in the sub-continent of Asia are factors that are presenting the market with immense opportunities to expand.

China biochip market accounted for the highest revenue share in 2018, and the nation is expected to showcase a similar growth pattern throughout the forecast period. Other significant markets in this region are Japan, India, South Korea, Australia and those collectively forming the Rest of Asia-Pacific.

However, the complexities of biological systems, high costs of instruments and a lack of common regulatory standards are factors that might challenge this market's growth in the future.

COMPETITIVE INSIGHTS

Some of the established players in this market are Bio-Rad Laboratories Inc., Cybrdi Inc., OriGene Technologies Inc., Gamida for Life Group, bioMerieux SA, PerkinElmer Inc., Fluidigm Corporation, IMGENEX, Samsung Electronics Inc., Cepheid Inc., Merck GmbH, Agilent Technology Inc., Thermo Fisher Scientific Inc., Biochain Institute Inc. and Illumina Inc.

Table of Contents
Product Code: 12920

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY & FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. ASIA PACIFIC IS THE FASTEST EVOLVING REGIONAL MARKET
    • 3.2.2. DNA CHIPS ACCOUNTS FOR THE LARGEST REVENUE SHARE OF TYPE SEGMENT
    • 3.2.3. HOSPITALS & DIAGNOSTICS CENTERS - KEY END-USER VERTICAL
    • 3.2.4. PROTEIN CHIP TYPE IS PROJECTED TO RISE AT HIGHEST GROWTH RATE

4. MARKET DYNAMICS

  • 4.1. PARENT MARKET ANALYSIS: GENOMICS & PROTEOMICS MARKET
  • 4.2. ETYMOLOGY OF BIOCHIPS MARKET
  • 4.3. MARKET DEFINITION & SCOPE
  • 4.4. MARKET DRIVERS
    • 4.4.1. RISING INCIDENCES OF CANCER
    • 4.4.2. INCREASED GOVERNMENT FUNDING, R&D INVESTMENT IN BIOTECHNOLOGY
    • 4.4.3. GROWING INTEREST IN PERSONALIZED MEDICINES
    • 4.4.4. SIGNIFICANT GROWTH IN THE HEALTHCARE EXPENDITURE ACROSS GEOGRAPHIES
  • 4.5. MARKET RESTRAINTS
    • 4.5.1. LACK OF HEALTHCARE COVERAGE
    • 4.5.2. AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
    • 4.5.3. LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
  • 4.6. MARKET OPPORTUNITIES
    • 4.6.1. TECHNOLOGICAL ADVANCEMENT IN THE BIOTECHNOLOGY
    • 4.6.2. IMMENSE GROWTH OPPORTUNITIES IN SUB-CONTINENT OF ASIA
    • 4.6.3. GROWING APPLICATIONS OF BIOCHIPS
  • 4.7. MARKET CHALLENGES
    • 4.7.1. COMPLEXITY OF BIOLOGICAL SYSTEMS
    • 4.7.2. LACK OF COMMON REGULATORY STANDARDS
    • 4.7.3. HIGH INSTRUMENTATION COST

5. MARKET BY TYPE

  • 5.1. DNA CHIPS
    • 5.1.1. AGRICULTURAL BIOTECHNOLOGY
    • 5.1.2. CANCER DIAGNOSTICS & TREATMENT
    • 5.1.3. DRUG DISCOVERY
    • 5.1.4. GENE EXPRESSION
    • 5.1.5. GENOMICS
    • 5.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
    • 5.1.7. OTHER DNA CHIPS APPLICATIONS
  • 5.2. LAB ON A CHIP
    • 5.2.1. CLINICAL DIAGNOSTICS
    • 5.2.2. DRUG DISCOVERY
    • 5.2.3. GENOMICS
    • 5.2.4. POINT OF CARE (POC) & IN-VITRO DIAGNOSIS (IVS)
    • 5.2.5. PROTEOMICS
    • 5.2.6. OTHER LAB ON A CHIP APPLICATIONS
  • 5.3. PROTEIN CHIPS
    • 5.3.1. DIAGNOSTICS
    • 5.3.2. DRUG DISCOVERY
    • 5.3.3. EXPRESSION PROFILING
    • 5.3.4. HIGH THROUGHPUT SCREENING
    • 5.3.5. PROTEOMICS
    • 5.3.6. OTHER PROTEIN CHIP APPLICATIONS
  • 5.4. OTHER CHIPS
    • 5.4.1. CELL ARRAYS
    • 5.4.2. TISSUE ARRAYS

6. MARKET BY SUBSTRATE MATERIALS

  • 6.1. GLASS
  • 6.2. POLYMERS
  • 6.3. SILICON
  • 6.4. OTHER SUBSTRATE MATERIALS

7. MARKET BY END-USERS

  • 7.1. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
  • 7.2. HOSPITALS & DIAGNOSTICS CENTERS
  • 7.3. ACADEMIC & RESEARCH INSTITUTE

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCE MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE
    • 8.1.3. BARGAINING POWER OF SUPPLIERS
    • 8.1.4. BARGAINING POWER OF BUYERS
    • 8.1.5. THREAT OF COMPETITIVE RIVALRY
  • 8.2. OPPORTUNITY MATRIX
  • 8.3. VENDOR LANDSCAPE
  • 8.4. VALUE CHAIN ANALYSIS
    • 8.4.1. RESEARCH & DEVELOPMENT
    • 8.4.2. RAW MATERIALS
    • 8.4.3. MANUFACTURING
    • 8.4.4. WHOLESALERS/RETAILERS/DISTRIBUTORS
    • 8.4.5. END-USERS
  • 8.5. LEGAL, POLICY & REGULATORY FRAMEWORK
  • 8.6. KEY BUYING CRITERIA
    • 8.6.1. COST
    • 8.6.2. APPLICATIONS
    • 8.6.3. PRODUCT TYPE
  • 8.7. INVESTMENT ANALYSIS
    • 8.7.1. BY END-USERS
    • 8.7.2. BY BIOCHIPS TYPE

9. GEOGRAPHICAL ANALYSIS - ASIA PACIFIC

  • 9.1. CHINA
  • 9.2. JAPAN
  • 9.3. INDIA
  • 9.4. SOUTH KOREA
  • 9.5. AUSTRALIA
  • 9.6. REST OF ASIA PACIFIC

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET SHARE ANALYSIS
  • 10.2. KEY COMPANY ANALYSIS
  • 10.3. CORPORATE STRATEGIES
    • 10.3.1. PARTNERSHIP & COLLABORATION
    • 10.3.2. MERGERS & ACQUISITIONS
  • 10.4. COMPANY PROFILES
    • 10.4.1. AGILENT TECHNOLOGY INC.
    • 10.4.2. BIOCHAIN INSTITUTE INC.
    • 10.4.3. BIOMERIEUX SA
    • 10.4.4. BIO-RAD LABORATORIES INC.
    • 10.4.5. CEPHEID INC.
    • 10.4.6. CYBRDI INC.
    • 10.4.7. FLUIDIGM CORPORATION
    • 10.4.8. GAMIDA FOR LIFE GROUP
    • 10.4.9. ILLUMINA INC.
    • 10.4.10. IMGENEX
    • 10.4.11. MERCK GMBH
    • 10.4.12. ORIGENE TECHNOLOGIES INC.
    • 10.4.13. PERKINELMER INC.
    • 10.4.14. SAMSUNG ELECTRONICS INC.
    • 10.4.15. THERMO FISHER SCIENTIFIC INC.

LIST OF TABLES

  • TABLE 1: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 2: NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017
  • TABLE 3: ASIA PACIFIC BIOCHIPS MARKET, BY TYPE, 2019-2027, (IN $ MILLION)
  • TABLE 4: ASIA PACIFIC DNA CHIPS MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 5: ASIA PACIFIC LAB ON A CHIP MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 6: ASIA PACIFIC PROTEIN CHIPS MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 7: ASIA PACIFIC OTHER CHIPS MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 8: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS
  • TABLE 9: ASIA PACIFIC BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
  • TABLE 10: ASIA PACIFIC BIOCHIPS MARKET, BY END-USERS, 2019-2027 (IN $ MILLIONS)
  • TABLE 11: OPPORTUNITY MATRIX
  • TABLE 12: VENDOR LANDSCAPE
  • TABLE 13: LEGAL, POLICY & REGULATORY FRAMEWORK
  • TABLE 14: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 15: LIST OF PARTNERSHIP & COLLABORATION
  • TABLE 16: LIST OF MERGERS & ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1: ASIA PACIFIC BIOCHIPS MARKET, BY END-USER, 2018 & 2027 (IN %)
  • FIGURE 2: ASIA PACIFIC BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 3: EVOLUTION & TRANSITION OF BIOCHIPS
  • FIGURE 4: WORLDWIDE HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP)
  • FIGURE 5: COMPARISON OF HEALTHCARE SPENDING PER CAPITA & OUT OF THE POCKET HEALTH EXPENDITURE
  • FIGURE 6: ASIA PACIFIC BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 7: ASIA PACIFIC DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)
  • FIGURE 8: ASIA PACIFIC DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)
  • FIGURE 9: ASIA PACIFIC DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
  • FIGURE 10: ASIA PACIFIC DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)
  • FIGURE 11: ASIA PACIFIC DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 12: ASIA PACIFIC DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION)
  • FIGURE 13: ASIA PACIFIC DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 14: ASIA PACIFIC BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)
  • FIGURE 15: ASIA PACIFIC LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)
  • FIGURE 16: ASIA PACIFIC LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
  • FIGURE 17: ASIA PACIFIC LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 18: ASIA PACIFIC LAB ON A CHIP MARKET, BY POINT OF CARE (POC) & IN-VITRO DIAGNOSIS (IVS), 2019-2027 (IN $ MILLION)
  • FIGURE 19: ASIA PACIFIC LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 20: ASIA PACIFIC LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)
  • FIGURE 21: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 22: ASIA PACIFIC PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)
  • FIGURE 23: ASIA PACIFIC PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
  • FIGURE 24: ASIA PACIFIC PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)
  • FIGURE 25: ASIA PACIFIC PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)
  • FIGURE 26: ASIA PACIFIC PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 27: ASIA PACIFIC PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 28: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 29: ASIA PACIFIC OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)
  • FIGURE 30: ASIA PACIFIC OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)
  • FIGURE 31: ASIA PACIFIC BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)
  • FIGURE 32: ASIA PACIFIC BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)
  • FIGURE 33: ASIA PACIFIC BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)
  • FIGURE 34: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
  • FIGURE 35: ASIA PACIFIC BIOCHIPS MARKET, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)
  • FIGURE 36: ASIA PACIFIC BIOCHIPS MARKET, BY HOSPITALS & DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS)
  • FIGURE 37: ASIA PACIFIC BIOCHIPS MARKET, BY ACADEMIC & RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)
  • FIGURE 38: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 39: VALUE CHAIN ANALYSIS
  • FIGURE 40: KEY IMPACT ANALYSIS
  • FIGURE 41: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET IN 2018, BY END-USER
  • FIGURE 42: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET IN 2018, BY TYPE
  • FIGURE 43: ASIA PACIFIC BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
  • FIGURE 44: CHINA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 45: JAPAN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 46: INDIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 47: SOUTH KOREA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 48: AUSTRALIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 49: REST OF ASIA PACIFIC BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 50: MARKET SHARE ANALYSIS OF KEY PLAYERS IN 2018 (IN %)
Back to Top